Filter posts

#BIOCEO19: We’re Out of Time to Address the Dire Market Failures in Antimicrobial Resistance

Here’s a statistic you might not have known: an estimated 700,000 people die each year …

Venture Creation is in Vogue

In the biotech industry, it’s common for a company to raise billions of dollars and …

Policy Outlook—How Could the Trump Administration’s Drug Reimbursement Proposals Affect Medical ...

In his State of the Union address, President Trump called on Congress to “do more” …

Market Outlook—Leveraging Market Corrections for M&A or IPOs

After a multi-year expansion of company formation and in biopharma valuations, 2018 was a year …

This Thanksgiving, We're Thankful for Modern Agriculture

Thanksgiving dinner as we know it wouldn’t be possible without modern agriculture and GMOs. These …

2018 BIO Investor Forum Wraps Up

As the stock market continued its volatile swings this week, investors at the BIO Investor …

A Patient-Centric Approach to Investing & Partnering

Thursday’s Plenary Luncheon Fireside Chat at the 2018 BIO Investor Forum (BIF) featured two industry leaders: …

Lessons from “View from the Board: Responding to an Acquisition Offer”

The “View from the Board: Responding to an Acquisition Offer” panel at the 2018 BIO …

On Track for a Record Breaking 2018 – #BIF18 Opening Plenary

Despite some recent market volatility, the industry is well positioned for long-term growth and success. …

Get To Know GMOs Month: Spooky GMO Myths – Debunked

Haunted houses, spooky costumes, and trick-or-treating are all scary delights of the Halloween season. But …